AURA
Aura Biosciences·NASDAQ
--
--(--)
--
--(--)
3.80 / 10
Netural
Sentiment is neutral (3.8/10) but fund‑flow scores 7.6/10, showing strong inflows across most investor sizes except extra‑large. Analyst consensus is a unanimous Buy, though with limited history and a recent 6.97% price decline, suggesting cautious optimism.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-26
InstitutionEvercore ISI Group
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for AURA?
- AURA holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.80/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
